Triumeq (Dolutegravir/Abacavir/Lamivudine)
Lupin has been granted tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Abacavir, Dolutegravir, and Lamivudine Tablets for Oral Suspension, 60 mg/5 mg/30 mg, to market a generic equivalent of Triumeq PD® Tablets for Oral Suspension, of ViiV Healthcare Company.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Triumeq contains dolutegravir, abacavir, and lamivudine — three powerful drugs that work together to stop HIV replication and maintain immune strength.
This once-daily tablet simplifies HIV therapy, improving adherence and quality of life.
It’s FDA-approved for HIV-1 treatment in adults and children over 12 years old.
Triumeq helps patients achieve and maintain undetectable viral loads, reducing the risk of transmission.
Patients should be screened for the HLA-B*5701 gene before starting Triumeq to avoid hypersensitivity reactions.
Common side effects include insomnia or mild nausea.
Triumeq stands as one of the most reliable all-in-one HIV treatments.
Be the first to review “Triumeq (Dolutegravir/Abacavir/Lamivudine)”
Related products
Depo-Provera Contraceptive Injection 150 mg/mL – Single Dose Vial (Rx)
Original price was: $77.$73.15Current price is: $73.15.Truvada (Emtricitabine/Tenofovir Disoproxil Fumarate)
Original price was: $2,200.$2,000Current price is: $2,000.PEP (Post-Exposure Prophylaxis) – Dolutegravir + Tenofovir + Emtricitabine
Original price was: $1,800.$1,700Current price is: $1,700.
$492Prometrium – Micronized Progesterone 100mg (Generic: Utrogestan) – 30 Capsules
Original price was: $28.$26.60Current price is: $26.60.
Reviews
There are no reviews yet.